Use of clove oil, eugenol and derivatives thereof in the preparation of medicines for histamine H3 receptor antagonists or inverse agonists
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CHENGDU MEDICAL COLLEGE
- Publication Date
- 2011-11-30
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the new application of clove oil, eugenol and derivatives thereof, in particular to the application in the preparation of medicaments of histamine H3 receptor antagonist or inverse agonist. Background technique
[0002] Histamine is produced by the decarboxylation of histidine by decarboxylase, and is a neurotransmitter with a wide range of physiological effects in the body. It has been found that histamine receptors consist of several different subtypes, namely H1, H2, H3 and H4 receptors. Both histamine H1 and H2 receptors are postsynaptic receptors, while histamine H3 receptor is a presynaptic autoreceptor widely distributed in the central nervous system and peripheral nervous system, in the central nervous system, the receptor The body not only participates in the regulation of the release, synthesis and metabolism of histamine in the brain, but also participates in the regulation of various neurotransmitters such as 5-hyd...